Company
United StatesPublic company, NASDAQ: BBNXBeta Bionics, Inc (NASDAQ: BBNX), Concord, MA – FDA Inspections
Inspection records and compliance data for Beta Bionics, Inc in Concord, Massachusetts. 1 FDA inspection on record, last inspected June 24, 2022. Publicly traded as NASDAQ: BBNX.
Company Profile
This profile covers Beta Bionics, Inc based in Concord, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 24, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 24, 2022 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1175587 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Beta Bionics, Inc
Stock ticker
BBNX
Exchange
NASDAQ
Share price
$15.46
Market cap
$840.5M
Price as of
November 6, 2026
FEI Number
3021695555
Address
300 Baker Ave Ste 301, Concord, Massachusetts 01742, United States
Country
United States
ID: ead6a5ac-9b27-4d61-84ca-bef633f0e12f